Thanks to kind reader Bobby Chariot for this Bollywood classic as the UK's best known PR genius hooks up with Britain's Buffet (sic).
Hello Share Bottlers. I stand by my belief for the six months or so that small and medium pharmaceutical concerns, and possibly the giants, too, are going to see higher profits over the next few years. It’s a question of growing demand from an ageing or obese population - and, in fact, both.
I am sorry to say this but the best caption contest entries this week were for Chris Oil behind bars. Perhaps it was the power of collective wishful thinking. You can see all the entries for this one HERE but the winner, pinching a line attributed to Disraeli but actually from Samuel Foote is..
In this podcast I look at United Cacao (CHOC) and also Gulfstands Petroleum (GPX) but the bulk of this edition covers the ramping of Horse Hill stocks by an unholy alliance of flip flop, Jabba and others. The trouble is that their analysis - I use the word loosely - is based on Leni-Maths and Leni-Maths does not add up.
Results for 2015 from the company with the exclusive right to develop, operate and sub-franchise Domino's Pizza stores in Poland, DP Poland (DPP) are headlined “System Sales up 22%. Total corporate stores deliver PLN+1m EBITDA for full year. Commissary makes strong contribution. Group EBITDA losses reduced by 31%”. Hmmm, use of ‘bullshit earnings’ in the headline then, let’s take a proper look…
Predictably and delightfully the Chris Oil Photo behind bars caption contest produced a raft of filthy entries. A raft of filthy entries, don't let that thought play on your mind too much Mr Oil. You can see the full list here but there is a clear winner but also a cracking runner up (John Rimmer). The winner, well done to Brian for:
Edi Truell, the founder of Tungsten (TUNG) has today quit the cash guzzling disaster story following the board rejecting his latest hare brained corpororate proposals. Mad Edi stepped down as CEO last July ago but remained, until today, as a NED. Does this make the shares more or less attractive?
This is not hard. The RNS from Servision (SEV) today is designed to ramp the shares ahead of a rescue bailout placing. It is bollocks if you add up the numbers. So too was the last RNS by the way. I have reported this POS to the FRC for dodgy revenue recognition policies, it almost certainly now has negative net current assets and is burning cash. There is a bailout placing looming and you should sell now. This company deserves to, and could well, go bust.
It is now Eighty years ago, February 4, 1936, that one of the most influential books of the last one hundred years was published, British economist, John Maynard Keynes’s The General Theory of Employment, Interest and Money was born what has become known as Keynesian Economics. Within less than a decade after its appearance, the ideas conquered the economics profession and become a guidebook for government economic policy then and to the current day.
Bluebird Merchant Ventures is set to list on the Standard List of the main market this week. We have a few shares in this company, let us be upfront about that. The CEO of Bluebird is Charles Barclay and I asked him a few questions ahead of the IPO
Lighthouse Group (LGT) on Friday noted an offer approach announcement from fellow AIM-listed financial services group AFH Financial and responded that it “believes that the indicative offer from AFH fundamentally undervalues the group and its prospects, especially in the context of the group's net cash position of £7.9 million as at 31 December 2015”.
Xcite Energy (XEL) has today announced a new reserves and resources report for its Bentley field. In three months time the company must refinance $125 million of bonds and right now net cash is sub $10 million and falling fast and it has zero revenues. Discussing the economics of a field where Xcite has failed patently to get the farm in partner needed to take it to production is like Hitler worryig about the seating plans for dinner in 1945 as Russian tanks entered Berlin. The only issue now is the scale of the shareholder wipeout. Heck, even respectable and normally cautious brokers such as SP Angel are now openly saying what I have said for an awfully long time, the smell is of toast and it is everywhere.
Hello Share Rattlers. It takes a bit of courage to go anywhere near oil shares these days. But we have to be thankful that the price of the ebony nectar seems to have stabilised a bit at around 40 dollars a barrel.
Before we turn to Lynda Duval who is a twitter diehard follower of David Lenigas par excellence, blowing him off by tweet on a daily basis, we go to last week's contest and an excellent winner. There were many fine entries as you can see HERE but the winner was a standout, a FastJet moron.
In today's podcast I argue that it matters little who runs the London Stock Exchange (LSE) as long as it is not the idiots in charge now. I then move onto unnacceptable faces of capitalism: slob Mike Ashley, greedy pig Phil Green and the Wicked Witch Cherie Blair
It has been too long since I revisited AIM-listed biotech Scancell (SCLP). Much has happened since I picked it as a share for 2015 but it is egg-on-face as the shares have more than halved, with (so far) no value-enhancing corporate deal on the table. The clinical trial on the company’s lead product, SCIB-1, is done but there have been funding questions – correctly called by Tom Winnifrith. Now we have an EIS-qualifying open offer on the table alongside a placing, with some detail of plans going forward. Still holding my shares, the question is what to do?
I covered proposals by the board of fully-listed Goldenport Holdings (GPRT) to dispose of its remaining fleet of container ships last weekend with an unequivocal “sell” stance, having previously given the company a wide berth (by more than the length of your average bargepole). The shares duly collapsed by more than 50% last week but I think that they are worthless and so still a sell at any price. But I have grave misgivings about how this whole thing has been handled by the company.
The first non-Tom story this week, way outside the top ten natch, is by Lucian Miers, representing the mysterious hedge fund billionaires/illuminati who fund ShareProphets with Can anyone help me get shares to borrow on UK Oil & Gas?. If you have some UKOG shares, please contact Lucian now, please don't take food out of his kid's mouths.
Those who listened to Australian fund manager John Hempton speak at the Gold and Bears show last November will know that attention to detail is very much his thing. They will have heard him mutter that he believed US Pharmaceutical giant Valeant, based in Canada, to be worthless. This has been a bold call with ranks of hedge fund royalty (the most prominent being the unbelievably arrogant Bill Ackman) lined up against him.
Optibiotix (OPTI) shares trade at 69p-70p having slipped on news yesterday which was "the wrong sort of good news". Fear not. The right sort is imminent. The wrong good news was that it has set up a 52% owned JV with the University of Manchester called SkinBiotix. Optibiotix says that:
The May edition of the UK Investor Show Magazine is live featuring three share tips from Gary Newman, the Greek meltown is worse than everyone thinks, and the EU is not fit for purpose plus a photofeature from the 2017 UK Investor Show.
The busting of a placing by AIM-listed UK Oil and Gas (UKOG) at 1p by Tom Winnifrith has caused a bit of controversy. It is not the first time he has been accused of being irresponsible by blowing the lid on a placing only for it to be pulled or the price dropped. Anyone left holding the baby gets their fingers burned – in the recent example quite badly if they had been buying into the ramp at north of 1.4p only to see the company raise cash at just 0.8p. Is it right?
The nauseating Mail on Sunday fawned upon Pippa Middleton and her ghastly family as they celebrated the "wedding of the Year". Bring on the revolution! But perhaps the real wedding of the year should be between our two very own in-house Bulletin Board Morons GrannySnuffs & Wildes who seem made for each other. can you find examples on the LSE Asylum, iii, ADVFN or twitter of comments more idiotic than those of our own dream team? If so post in the comments section below, the deadline is midnight Sunday 28th May.
Having bought itself some time by declaring an initial sack-the-board General Meeting requisition “invalid” (a revised, valid requisition announced by it at an attempted ‘no one watching o’clock’, 5:15 pm, on Friday), Infrastrata (INFA) has this afternoon made a “Review of stategic options & project update” announcement...
AIM-listed travel agent and wannabe Greek holiday resort developer Minoan (MIN) announced a small bolt-on acquisition this morning….and a placing. Oh, and an update on its debt facility due to expire at the end of June. It is disappointing to see a placing (at 9p), but in the general scheme of things it is a relatively small amount so the pill is sugared to some extent.
It was a keen competition this week. But we have found a winner.
Take a look! European investors are clearly failing to grasp the very significant financial and commercial benefits available for Orphan or Rare Disease drug developers. So much so in fact, that sector-focussed Amryt Pharma (AMYT) finds no quoted peers in London, yet a good basket of NASDAQ-listed comparables are seen to command a significant premium despite mostly being pre-revenue and somewhat earlier in their development. Such anomalies can and, of course, do rapidly correct.
Any reader of my pieces will know I hold Challenger Acquisitions (CHAL) in pretty low regard but the outrageous ramping that has now gone on for the last four trading days is an absolute disgrace and the FCA should take a look. I’ll explain.
I have already covered the dire financials of Eden Research that indicate it is just months from trading whilst insolvent as well as its panning by the Financial Reporting Council (FRC) - in response to my urgings. Now to today's monstrous half truths - I am perhaps being 50% too charitable in that description.
Eden Research (EDEN) has today published godawful results and admitted that my very good friends at the Financial Reporting Council (FRC) investigated it - after I requested such an investigation - and have forced it to restate past numbers. It claims that the FRC has now settled all matters. Au contraire. that is another lie from the fraudsters and there are many more porkies in this statement. Truly, the pants of shamed PR Paul Queenie McManus of Walbrook will be cinders and ash after this effort. This all came out as Eden published Godawful numbers for calendar 2016.
The sold-out success that was the 1st April 2017 UK Investor Show again saw five 'Dragon's Den' sessions where a number of CEOs each gave a pitch and three Dragons each picked one stock for a £1,000 investment. How are they faring so far?...
With some great investigative journalism of which this website would have been proud, Brokerman Dan flushed it out a few weeks ago. The former bank robber - correctly - stated that Andalas (ADL) was looking to raise £1 million at 0.06p and the AIM listed crock of shit suspended its shares. Today they are unsuspended after the company raised £600,000 at 0.1p. It says this is at a premium to the suspension price. But it is a spoof, Andalas is still bust. It is insolvent as of today!
Malcolm Stacey is old enough to know about King Canute. In fact he is so old that he was there as a boy when the King sat in his chair on the beach and attempted to turn back the tide. Malcolm surely you remember the day as if it was yesterday? In which case why do you forget this valuable lesson when it comes to Inmarsat (ISAT) and your article today in which you misquote me and get it wrong in so many other ways.
"A credit crunch is brewing and when it happens, the UK is going to get hurt." These are not my words but the start of the Editorial in this weekend’s Guardian. The article then went on to say "That is the message emerging from senior executives in the financial services industry, who do not think Britain has changed that much since the 2008 credit disaster and the devastating crash that followed. Three developments lie at the heart of this disturbing analysis: spectacular growth in the sale of second mortgages, car loans and credit cards." I would heartily agree with these comments as this is my experience too. But what the article fails to say is that the UK is not alone in this debt bubble - once more it is a Global issue.
Hello Share Scoopers. There have been quite a few occasions now that I’ve commended a Footsie satellite company to your attention. On each mention, as I recall, the share grew in value. However, last year the shares took a big knock.
One of the most fascinating scenes I’ve seen for some time is the sight of Big Donald jigging around with some sort of weird entertainment put on by the Saudi’s for the President's visit. It almost made me forget the big benefit of this amiable state visit on share shifters like us. And that of course is that the President’s friendly reception sent the oil price up.
An announcement from Corero Network Security (CNS) with a headline “Corero Tier 1 Internet service provider customer GTT Communications, Inc. launches DDoS Mitigation service”. Then “further to the announcement on 19 April 2017 regarding a Global Tier 1 Internet service provider customer win… announces that the customer, GTT Communications, Inc. (NYSE: GTT), has launched its DDoS Mitigation service”. “Global Tier 1” now hey! And you what? The contract win has already been announced? Ramptastic…
Together Robert Sutherland Smith and Tom Winnifrith have now been working in finance for 71 years - the last ten or so together. Tom wishes to stress that RSS accounts for most of that, the great value investor starting his City career at the Unilever Pension Fund the year before Tom was born. In this book they outline 71 tricks of the trade for making money from shares.
Get the first ShareProphets Pocket Guide ebook, EIS - Buying shares with numerous tax breaks. Want to cut your income tax bill, get loss relief if your AIM listed shares go down, pay no CGT, avoid IHT - EIS could be the way and this book explains how.
Most investment books seem to be large enough to keep the front door open and while some contain gems it is hard to find them amid the verbiage. The aim here is to produce a short guide which simply cuts to the chase. I hope that it will provide food for thought for everyone from beginner to expert but whoever you are it should be quick and easy to read and digest.
Search ShareProphets |
Stock market news |
Recent Comments |